EDIT
Price
$2.40
Change
-$0.09 (-3.61%)
Updated
Oct 23 closing price
Capitalization
368.59M
16 days until earnings call
Intraday BUY SELL Signals
RPRX
Price
$63.86
Change
+$0.11 (+0.17%)
Updated
Oct 23 closing price
Capitalization
28.44B
11 days until earnings call
Intraday BUY SELL Signals
VRTX
Price
$523.93
Change
-$11.24 (-2.10%)
Updated
Oct 23 closing price
Capitalization
132.8B
9 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

EDIT or RPRX or VRTX

EDIT vs RPRX vs VRTX Comparison Chart in %
loading
loading
loading
View a ticker or compare two or three
Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for EDIT with price predictions
Oct 23, 2026

Momentum Indicator for EDIT turns negative, indicating new downward trend

EDIT saw its Momentum Indicator move below the 0 level on October 13, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned negative. In 78 of the 84 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for EDIT turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 46 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

EDIT moved below its 50-day moving average on October 12, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EDIT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for EDIT entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 50 of 63 cases where EDIT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.

Following a +9.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where EDIT advanced for three days, in 179 of 224 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

EDIT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.501) is normal, around the industry mean (3.043). P/E Ratio (-3.636) is within average values for comparable stocks, (-1.361). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. P/S Ratio (5.855) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. EDIT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EDIT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for RPRX with price predictions
Oct 23, 2026

RPRX in upward trend: price rose above 50-day moving average on October 15, 2026

RPRX moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend. In 31 of 49 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 63%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on RPRX as a result. In 46 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 53%.

The Moving Average Convergence Divergence (MACD) for RPRX just turned positive on October 14, 2026. Looking at past instances where RPRX's MACD turned positive, the stock continued to rise in 31 of 52 cases over the following month. The odds of a continued upward trend are 60%.

The 10-day moving average for RPRX crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.

Following a +2.75% 3-day Advance, the price is estimated to grow further. Considering data from situations where RPRX advanced for three days, in 176 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RPRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 49%.

RPRX broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for RPRX entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 4 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 23 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. RPRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.162) is normal, around the industry mean (3.043). P/E Ratio (34.150) is within average values for comparable stocks, (-1.361). Projected Growth (PEG Ratio) (1.360) is also within normal values, averaging (9.059). Dividend Yield (0.015) settles around the average of (133.535) among similar stocks. P/S Ratio (12.870) is also within normal values, averaging (438.009).

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for VRTX with price predictions
Oct 23, 2026

VRTX's RSI Oscillator climbs out of oversold territory

The RSI Indicator for VRTX moved out of oversold territory on October 14, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 14 similar instances when the indicator left oversold territory. In 12 of the 14 cases the stock moved higher. This puts the odds of a move higher at 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on VRTX as a result. In 59 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.

The Moving Average Convergence Divergence (MACD) for VRTX just turned positive on October 20, 2026. Looking at past instances where VRTX's MACD turned positive, the stock continued to rise in 38 of 60 cases over the following month. The odds of a continued upward trend are 63%.

VRTX moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +3.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where VRTX advanced for three days, in 237 of 367 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The 10-day moving average for VRTX crossed bearishly below the 50-day moving average on October 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 47%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VRTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 42%.

VRTX broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for VRTX entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 16 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 24 (best 1 - 100 worst), indicating outstanding price growth. VRTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 41 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.558) is normal, around the industry mean (3.043). P/E Ratio (30.267) is within average values for comparable stocks, (-1.361). Projected Growth (PEG Ratio) (1.939) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. P/S Ratio (10.449) is also within normal values, averaging (438.009).

FUNDAMENTALS RATINGS
EDIT vs RPRX vs VRTX: Fundamental Ratings
EDIT
RPRX
VRTX
OUTLOOK RATING
1..100
823432
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
91
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
1002316
SMR RATING
1..100
999741
PRICE GROWTH RATING
1..100
743824
P/E GROWTH RATING
1..100
23439
SEASONALITY SCORE
1..100
50n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EDIT's Valuation (48) in the Biotechnology industry is somewhat better than the same rating for RPRX (91) in the Pharmaceuticals Major industry, and is somewhat better than the same rating for VRTX (92) in the Biotechnology industry. This means that EDIT's stock grew somewhat faster than RPRX’s and somewhat faster than VRTX’s over the last 12 months.

VRTX's Profit vs Risk Rating (16) in the Biotechnology industry is in the same range as RPRX (23) in the Pharmaceuticals Major industry, and is significantly better than the same rating for EDIT (100) in the Biotechnology industry. This means that VRTX's stock grew similarly to RPRX’s and significantly faster than EDIT’s over the last 12 months.

VRTX's SMR Rating (41) in the Biotechnology industry is somewhat better than the same rating for RPRX (97) in the Pharmaceuticals Major industry, and is somewhat better than the same rating for EDIT (99) in the Biotechnology industry. This means that VRTX's stock grew somewhat faster than RPRX’s and somewhat faster than EDIT’s over the last 12 months.

VRTX's Price Growth Rating (24) in the Biotechnology industry is in the same range as RPRX (38) in the Pharmaceuticals Major industry, and is somewhat better than the same rating for EDIT (74) in the Biotechnology industry. This means that VRTX's stock grew similarly to RPRX’s and somewhat faster than EDIT’s over the last 12 months.

RPRX's P/E Growth Rating (4) in the Pharmaceuticals Major industry is in the same range as EDIT (23) in the Biotechnology industry, and is somewhat better than the same rating for VRTX (39) in the Biotechnology industry. This means that RPRX's stock grew similarly to EDIT’s and somewhat faster than VRTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EDITRPRXVRTX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
66%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
56%
Bearish Trend 1 day ago
65%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
53%
Bullish Trend 1 day ago
69%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
63%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
57%
Bullish Trend 1 day ago
65%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 1 day ago
56%
Bullish Trend 2 days ago
65%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 18 days ago
49%
Bearish Trend 11 days ago
42%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
51%
Bearish Trend 1 day ago
62%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
47%
COMPARISON
Comparison
Oct 24, 2026
Stock price -- (EDIT: $2.40, RPRX: $63.86, VRTX: $523.93)
Brand notoriety: EDIT, RPRX and VRTX are all not notable
The three companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 43%, RPRX: 136%, VRTX: 71%
Market capitalization -- EDIT: $368.59M, RPRX: $28.44B, VRTX: $132.8B
$EDIT is valued at $368.59M, while RPRX has a market capitalization of $28.44B, and VRTX's market capitalization is $132.8B. The market cap for tickers in this @Biotechnology ranges from $58 to $132.8B. The average market capitalization across the @Biotechnology industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 1 FA rating(s) are green while RPRX’s FA Score has 2 green FA rating(s), and VRTX’s FA Score reflects 2 green FA rating(s).

  • EDIT’s FA Score: 1 green, 4 red.
  • RPRX’s FA Score: 2 green, 3 red.
  • VRTX’s FA Score: 2 green, 3 red.
According to our system of comparison, VRTX is a better buy in the long-term than RPRX, which in turn is a better option than EDIT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 3 TA indicator(s) are bullish while RPRX’s TA Score has 5 bullish TA indicator(s), and VRTX’s TA Score reflects 5 bullish TA indicator(s).

  • EDIT’s TA Score: 3 bullish, 5 bearish.
  • RPRX’s TA Score: 5 bullish, 5 bearish.
  • VRTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VRTX is a better buy in the short-term than RPRX, which in turn is a better option than EDIT.

Price Growth

EDIT (@Biotechnology) experienced а +2.13% price change this week, while RPRX (@Biotechnology) price change was +4.76% , and VRTX (@Biotechnology) price fluctuated +4.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was -16.30%, and the average quarterly price growth was -16.78%.

Reported Earning Dates

EDIT is expected to report earnings on Nov 09, 2026.

RPRX is expected to report earnings on Nov 04, 2026.

VRTX is expected to report earnings on Nov 02, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
EDIT
Daily Signal:
Gain/Loss:
RPRX
Daily Signal:
Gain/Loss:
VRTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

RPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPRX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RPRX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPRX
1D Price
Change %
RPRX100%
+0.17%
AXON - RPRX
48%
Loosely correlated
+1.39%
INCY - RPRX
47%
Loosely correlated
-1.04%
VRTX - RPRX
45%
Loosely correlated
-2.10%
RIGL - RPRX
40%
Loosely correlated
-1.49%
EXEL - RPRX
39%
Loosely correlated
-1.19%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TMB24.92N/A
N/A
Thornburg Multi Sector Bond ETF (TMB)
VBCC74.39-0.06
-0.07%
Vanguard Target Maturity 2029 Corporate Bond ETF (VBCC)
ENS.X5.473698-0.023710
-0.43%
Ethereum Name Service cryptocurrency
AAOG0.83-0.02
-2.14%
Leverage Shares 2X Long AAOI Daily ETF (AAOG)
XNO.X0.328824-0.007539
-2.24%
Nano cryptocurrency